Paper36948284
Doxorubicin-loaded micelles in tumor cell-specific chemotherapy.
Almajidi YQ and 10 others. Environ Res, 2023. Cited by 53 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Doxorubicin-loaded micelles in tumor cell-specific chemotherapy. Papers, record 36948284. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36948284
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Micelles | Major topic |
| Doxorubicin | Major topic |
| Humans | |
| Cell Line, Tumor | |
| Hydrogen-Ion Concentration |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42604221 | Progress in high-throughput screening for drug and material discovery in orthopedic diseases: a literature review. | PeerJ | 2026 | https://conductscience.org/library/papers/42604221 | PubMed |
| 42368044 | Doxorubicin-Loaded Poly(Substituted Glycolide)-Based Nanoparticles for Long-Term Storage. | ACS Omega | 2026 | https://conductscience.org/library/papers/42368044 | PubMed |
| 42174494 | Anticancer effects of bisabolol oxide A-Loaded Micellar/Liposomal nanoparticles on DU-145 cells with deregulation of miR-34a and miR-181a: in silico and in vitro studies. | BMC Biotechnol | 2026 | https://conductscience.org/library/papers/42174494 | PubMed |
| 42108493 | Research Progress of Cuproptosis in Orthopaedics: Opportunities and Challenges. | J Cell Mol Med | 2026 | https://conductscience.org/library/papers/42108493 | PubMed |
| 41854962 | Nanoparticles for Doxorubicin Delivery: Advances in Carrier Design and Synergistic Cancer Therapy. | Top Curr Chem (Cham) | 2026 | https://conductscience.org/library/papers/41854962 | PubMed |
| 41809894 | Integrating CRISPR/Cas technology with clinical trials: Principles, progress and challenges. | Asian J Pharm Sci | 2025 | https://conductscience.org/library/papers/41809894 | PubMed |
| 41721972 | Amelioration of doxorubicin-mediated nephrotoxicity through antioxidant and anti-apoptotic mechanisms of 5,4'-dihydroxy-6,8-dimethoxy-7-O-rhamnosylflavone. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/41721972 | PubMed |
| 41685914 | Recent Advances in Integrating Graphene into Polymeric Nanocomposite Hydrogels for Biomedical Applications. | Macromol Biosci | 2026 | https://conductscience.org/library/papers/41685914 | PubMed |
| 41471080 | Development and Antitumor Evaluation of Doxorubicin-Loaded Two-Layered Sheets for Local Chemotherapy via Direct Drug Application to the Tumor Surface. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41471080 | PubMed |
| 41382246 | Synergistic potential of Ivermectin and doxorubicin in oral squamous cell carcinoma: an in vitro investigation. | BMC Pharmacol Toxicol | 2025 | https://conductscience.org/library/papers/41382246 | PubMed |
| 41171579 | Revolutionizing Breast Cancer Treatment: Harnessing Ehrlich Ascites Carcinoma Model, Cancer Metabolism, and Nanotechnology-Enhanced Chemotherapy for Improved Patient Outcomes. | Cell Biochem Biophys | 2026 | https://conductscience.org/library/papers/41171579 | PubMed |
| 41029834 | Sodium alginate-hyaluronic acid composite particles for doxorubicin delivery: in vitro characterization and cytotoxicity evaluation. | BMC Res Notes | 2025 | https://conductscience.org/library/papers/41029834 | PubMed |
| 40983837 | Glutathione-Responsive Supramolecular Micelles Based on β-Cyclodextrin Construction: Combining Photodynamic Therapy and Chemotherapy for Cancer Treatment. | Pharm Res | 2025 | https://conductscience.org/library/papers/40983837 | PubMed |
| 40565261 | Elacridar Inhibits BCRP Protein Activity in 2D and 3D Cell Culture Models of Ovarian Cancer and Re-Sensitizes Cells to Cytotoxic Drugs. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40565261 | PubMed |
| 40497954 | The cGAS/STING Pathway: Friend or Foe in Regulating Cardiomyopathy. | Cells | 2025 | https://conductscience.org/library/papers/40497954 | PubMed |
| 40281790 | Advances in Targeted Delivery of Doxorubicin for Cancer Chemotherapy. | Bioengineering (Basel) | 2025 | https://conductscience.org/library/papers/40281790 | PubMed |
| 40198734 | Trillin protects against doxorubicin-induced cardiotoxicity through regulating Nrf2/HO-1 signaling pathway. | PLoS One | 2025 | https://conductscience.org/library/papers/40198734 | PubMed |
| 40181461 | 5-Methylcytosine RNA modification and its roles in cancer and cancer chemotherapy resistance. | J Transl Med | 2025 | https://conductscience.org/library/papers/40181461 | PubMed |
| 40134771 | A supervised machine-learning analysis of doxorubicin-loaded electrospun nanofibers and their anticancer activity capabilities. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/40134771 | PubMed |
| 40116873 | NLRP3 inflammasome-based therapies by natural products: a new development in the context of cancer therapy. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40116873 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TOP2A | 7153 | PubTator's text mining | https://conductscience.org/library/genes/7153 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36948284
GET https://conductscience.org/api/papers/v1/36948284/cited_by?page=2